Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartphone app could revolutionize insulin dosing for diabetics

NCT ID NCT07234500

First seen Nov 18, 2025 · Last updated May 22, 2026 · Updated 27 times

Summary

This study tests whether a mobile app can help people with type 1 diabetes better manage their insulin doses and blood sugar levels. About 50 participants aged 15 and older will either use the app alongside standard care or receive standard care alone for 3 months. The main goal is to see if the app leads to improved blood sugar control, measured by HbA1c levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE ONE DIABETES MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Faiha Specialized Diabetes, Endocrine and Metabolism Center at Al-Faiha Teaching hospital

    Basra, Basrah, Iraq

Conditions

Explore the condition pages connected to this study.